Finless Foods
a Berkeley pioneer developing sushi-grade cultivated Pacific bluefin tuna, financing its 2025 launch pathway through regulated investment crowdfunding alongside ongoing institutional backing.
- Country
- United States
Pilot
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cultured seafood | food-alt-protein | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.